Covis Pharma B.V.
Industry
- Pharmaceuticals
- Vaccines
- Specialty Pharmaceuticals
Other Names/Subsidiaries
- Covis Group
- Covis pharmaceuticals
- AMAG Pharmaceuticals
Latest on Covis Pharma B.V.
The role of the US Food and Drug Administration’s accelerated approval council in the approval and withdrawal of products is drawing attention as 2025 begins. A new Health and Human Services’ Office o
The US Food and Drug Administration intends to convene an advisory committee when its drug or biologic centers are considering withdrawal of an accelerated approval product. A new draft guidance on
US Food and Drug Administration Principal Deputy Commissioner Namandjé Bumpus’ decision to leave by the end of the year means there is no obvious, internal candidate to serve as acting commissioner in
US Food and Drug Administration Principal Deputy Commissioner Namandjé Bumpus’ decision to leave by the end of the year means there is no obvious, internal candidate to serve as acting commissioner in